O
ELV icon

OppenheimerFunds’s Elevance Health ELV Stock Holding History

OppenheimerFunds’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$707M Sell
2,464,719
-33,635
-1% -$9.73M 0.88% 15
2018
Q4 		$656M Sell
2,498,354
-39,330
-2% -$10.8M 0.94% 14
2018
Q3 		$695M Buy
2,537,684
+125,203
+5% +$32.5M 0.81% 16
2018
Q2 		$574M Buy
2,412,481
+77,194
+3% +$17.9M 0.69% 21
2018
Q1 		$513M Buy
2,335,287
+171,708
+8% +$40.3M 0.64% 28
2017
Q4 		$487M Buy
2,163,579
+88,627
+4% +$18.9M 0.59% 31
2017
Q3 		$394M Sell
2,074,952
-14,021
-0.7% -$2.67M 0.48% 51
2017
Q2 		$393M Sell
2,088,973
-45,995
-2% -$8.26M 0.49% 53
2017
Q1 		$353M Sell
2,134,968
-4,248
-0.2% -$676K 0.43% 60
2016
Q4 		$308M Sell
2,139,216
-259,899
-11% -$34.8M 0.39% 66
2016
Q3 		$301M Buy
2,399,115
+26,541
+1% +$3.43M 0.38% 69
2016
Q2 		$312M Buy
2,372,574
+78,983
+3% +$10.8M 0.41% 65
2016
Q1 		$319M Sell
2,293,591
-2,605
-0.1% -$348K 0.42% 62
2015
Q4 		$320M Buy
2,296,196
+129,854
+6% +$17.9M 0.41% 62
2015
Q3 		$303M Sell
2,166,342
-382,660
-15% -$57.5M 0.41% 62
2015
Q2 		$418M Buy
2,549,002
+34,100
+1% +$5.45M 0.48% 47
2015
Q1 		$388M Sell
2,514,902
-193,340
-7% -$27.5M 0.43% 52
2014
Q4 		$340M Buy
2,708,242
+8,210
+0.3% +$1.01M 0.38% 67
2014
Q3 		$323M Sell
2,700,032
-93,610
-3% -$10.7M 0.36% 67
2014
Q2 		$301M Sell
2,793,642
-770,890
-22% -$79.4M 0.33% 78
2014
Q1 		$355M Sell
3,564,532
-916,120
-20% -$82.9M 0.42% 56
2013
Q4 		$414M Sell
4,480,652
-4,535,152
-50% -$403M 0.5% 46
2013
Q3 		$754M Buy
9,015,804
+4,381,842
+95% +$376M 0.5% 39
2013
Q2 		$379M Buy
+4,633,962
New +$347M 0.55% 34

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

OppenheimerFunds's ELV Position: Q1 2019 in Review

OppenheimerFunds reduced its Elevance Health (ELV) stake by 1.3% in Q1 2019, selling an estimated $9.73M and leaving 2,464,719 shares worth $707M. The position accounts for 0.88% of the portfolio, ranked #15.

OppenheimerFunds first reported a position in ELV in Q2 2013 and has held it in 24 quarters since. The position peaked at $754M in Q3 2013. 1,076 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

  • OppenheimerFunds held 2,464,719 shares of Elevance Health worth $707M as of Q1 2019.
  • OppenheimerFunds sold 33,635 Elevance Health shares in Q1 2019, an estimated $9.73M.
  • Elevance Health made up 0.88% of OppenheimerFunds's portfolio in Q1 2019, its #15 holding.
  • OppenheimerFunds first reported a position in Elevance Health in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Elevance Health position peaked at $754M in Q3 2013.
  • 1,076 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.